HHT
8 Henderson Hill Ct, Monkton, MD, 21111, United States
Overview
Cure Hereditary Hemorrhagic Telangiectasia offers a variety of educational materials and tools to help learn about that as well as connect with expert care. They find a hereditary hemorrhagic telangiectasia treatment center or explore their resource library. They are a nonprofit organization that provides diagnosis and treatment options for telangiectasia.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Funding Platform
- Health Care
- Non Profit
Investment portfolio
- BE WTR
Participated · Series C · Oct 2024
BE WTR is a Swiss-founded company offering sustainable, premium on-site water solutions that deliver filtered, flavored water in stylish glass bottles as a circular alternative to single-use plastics. Its core product portfolio centers on water distribution, purification and circular bottling operations for residential, commercial and hospitality customers. The company recently launched in Singapore and is pursuing broader expansion across Asia. BE WTR plans to use new funding to enhance its market-leading product lineup and to invest in research and development. Management also intends to extend the company’s international footprint, including targeted openings in China and North America and further activity in Switzerland. The firm emphasizes innovation in sustainability and aims to set new benchmarks for water consumption and waste reduction.
Team
Chris Hughes
Chair, Scientific and Medical Advisory Council
LinkedIn